Nintedanib & Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF) in King Abdulaziz Medical City (KAMC), Riyadh - Real Life Data

被引：0
|
作者：
Khan, A. M. [1 ]
Al-Jahdali, H. H. [2 ]
Alharbi, A. S. [3 ]
Rajendram, R. [1 ]
Obaidi, M. [1 ]
Alghamdi, B. [1 ]
Hassan, I. [1 ]
机构：
[1] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Pulmonol Div, Med, Riyadh, Saudi Arabia
[2] King Fahad Natl Guard Hosp, Riyadh, Saudi Arabia
[3] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Pulmonolgy, Med, Riyadh, Saudi Arabia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1917
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
    Khan, Mohammed
    Sherbini, Nahed
    Alyami, Sami
    Al-Harbi, Abdullah
    Al-Ghamdi, Majed
    Alrajhi, Suliman
    Rajendram, Rajkumar
    Al-Jahdali, Hamdan
    ANNALS OF THORACIC MEDICINE, 2023, 18 (01) : 45 - 51
  • [2] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] Real-life Data on the Safety and Tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) Patients: A Single-Centre Study
    Thong, L.
    Bowen, B.
    Henry, M. T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S28 - S29
  • [4] Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Cameli, Paolo
    Bergantini, Laura
    D'Alessandro, Miriana
    Refini, Rosa Metella
    Pieroni, Maria
    Alonzi, Valerio
    Sestini, Piersante
    Bargagli, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] HEPATIC DISORDERS OF PIRFENIDONE OR NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) A SYSTEMATIC REVIEW
    Singla, D.
    Mahapatra, S.
    Dey, A.
    John, A.
    VALUE IN HEALTH, 2022, 25 (12) : S218 - S218
  • [7] Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study
    Yin, Lorraine Thong Wan
    Bowen, Bernadette
    Henry, Micahel
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [8] The Prevalence of Depression in Survivors of Acute Myocardial Infarction and Gender Differences in King Abdulaziz Medical City (KAMC), Riyadh
    Suliman, Ihab
    Almkainzi, Hanan A.
    Alsubaie, Abdullah M.
    Alqahtani, Faisal N.
    Alkhudairy, Faris A.
    Alrodiman, Osama
    Nahhas, Alwaleed K.
    Alnasser, Abdulaziz M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [9] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
    Mulholland, S. A.
    Al Jbour, K.
    Steer, H.
    Gutsche, M.
    Foley, N.
    Srivastava, R.
    Sharp, C.
    Adamali, H. I.
    Barratt, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre
    Bargagli, E.
    Piccioli, C.
    Rosi, E.
    Torricelli, E.
    Turi, L.
    Piccioli, E.
    Pistolesi, M.
    Ferrari, K.
    Voltolini, L.
    PULMONOLOGY, 2019, 25 (03): : 149 - 153
12345